Assignment of Assignor's Interest

Recorded: 2025-04-25 Pages: 27

Assignor

F. HOFFMANN-LA ROCHE AG

Executed: 2014-11-14

Assignee

NANOSTRING TECHNOLOGIES, INC.

530 FAIRVIEW AVE NORTH, SUITE 2000, SEATTLE, WASHINGTON, 98109

Covered Property (1)

Obinutuzumab Treatment of a Dlbcl Patient Subgroup

Application: 18/163,810 →

Publication: US 2023/0348611

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.